SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Santoni C)
 

Search: WFRF:(Santoni C) > (2020-2024) > CD155: A Multi-Func...

CD155: A Multi-Functional Molecule in Tumor Progression

Molfetta, R (author)
Zitti, B (author)
Karolinska Institutet
Lecce, M (author)
show more...
Milito, ND (author)
Stabile, H (author)
Fionda, C (author)
Cippitelli, M (author)
Gismondi, A (author)
Santoni, A (author)
Paolini, R (author)
show less...
 (creator_code:org_t)
2020-01-30
2020
English.
In: International journal of molecular sciences. - : MDPI AG. - 1422-0067. ; 21:3
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • CD155 is an adhesion molecule belonging to the Nectin/Nectin-like family often overexpressed on tumor cells and involved in many different processes such as cell adhesion, migration and proliferation. In contrast to these pro-tumorigenic functions, CD155 is also a ligand for the activating receptor DNAM-1 expressed on cytotoxic lymphocytes including Natural Killer (NK) cells and involved in anti-tumor immune response. However, during tumor progression inhibitory receptors for CD155 are up-regulated on the surface of effector cells, contributing to an impairment of their cytotoxic capacity. In this review we will focus on the roles of CD155 as a ligand for the activating receptor DNAM-1 regulating immune surveillance against cancer and as pro-oncogenic molecule favoring tumor proliferation, invasion and immune evasion. A deeper understanding of the multiple roles played by CD155 in cancer development contributes to improving anti-tumor strategies aimed to potentiate immune response against cancer.

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view